Folic Acid Supplements in Pregnancy and Severe Language Delay in Children
Overview
Authors
Affiliations
Context: Prenatal folic acid supplements reduce the risk of neural tube defects and may have beneficial effects on other aspects of neurodevelopment.
Objective: To examine associations between mothers' use of prenatal folic acid supplements and risk of severe language delay in their children at age 3 years.
Design, Setting, And Patients: The prospective observational Norwegian Mother and Child Cohort Study recruited pregnant women between 1999 and December 2008. Data on children born before 2008 whose mothers returned the 3-year follow-up questionnaire by June 16, 2010, were used. Maternal use of folic acid supplements within the interval from 4 weeks before to 8 weeks after conception was the exposure. Relative risks were approximated by estimating odds ratios (ORs) with 95% CIs in a logistic regression analysis.
Main Outcome Measure: Children's language competency at age 3 years measured by maternal report on a 6-point ordinal language grammar scale. Children with minimal expressive language (only 1-word or unintelligible utterances) were rated as having severe language delay.
Results: Among 38,954 children, 204 (0.5%) had severe language delay. Children whose mothers took no dietary supplements in the specified exposure interval were the reference group (n = 9052 [24.0%], with severe language delay in 81 children [0.9%]). Adjusted ORs for 3 patterns of exposure to maternal dietary supplements were (1) other supplements, but no folic acid (n = 2480 [6.6%], with severe language delay in 22 children [0.9%]; OR, 1.04; 95% CI, 0.62-1.74); (2) folic acid only (n = 7127 [18.9%], with severe language delay in 28 children [0.4%]; OR, 0.55; 95% CI, 0.35-0.86); and (3) folic acid in combination with other supplements (n = 19,005 [50.5%], with severe language delay in 73 children [0.4%]; OR, 0.55; 95% CI, 0.39-0.78).
Conclusion: Among this Norwegian cohort of mothers and children, maternal use of folic acid supplements in early pregnancy was associated with a reduced risk of severe language delay in children at age 3 years.
Bortolus R, Filippini F, Cipriani S, Trevisanuto D, Marchetti F, Mastroiacovo P Eur J Obstet Gynecol Reprod Biol X. 2025; 25:100370.
PMID: 40027877 PMC: 11869910. DOI: 10.1016/j.eurox.2025.100370.
International expert consensus on micronutrient supplement use during the early life course.
Cetin I, Devlieger R, Isolauri E, Obeid R, Parisi F, Pilz S BMC Pregnancy Childbirth. 2025; 25(1):44.
PMID: 39833730 PMC: 11744953. DOI: 10.1186/s12884-024-07123-5.
Invited Perspective: Protect and Serve-The Potential Role of Folate in Lead Risk Reduction.
Dickerson A, Schmidt R Environ Health Perspect. 2024; 132(10):101302.
PMID: 39412271 PMC: 11481931. DOI: 10.1289/EHP16216.
Analysis of Maternal and Fetal Oxidative Stress During Delivery with Epidural Analgesia.
Yuba T, Koyama Y, Kinishi Y, Uokawa R, Ootaki C, Shimada S Reprod Sci. 2024; 31(9):2753-2762.
PMID: 38727999 PMC: 11393216. DOI: 10.1007/s43032-024-01580-1.
Risk of Excess Maternal Folic Acid Supplementation in Offspring.
Xu X, Zhang Z, Lin Y, Xie H Nutrients. 2024; 16(5).
PMID: 38474883 PMC: 10934490. DOI: 10.3390/nu16050755.